Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SmofKabiven vs hospital-compounded TPN after elective gastrointestinal surgery
CTR20182440Phase 3Completed
- Sponsor
- Fresenius Kabi
- Start
- Dec 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of SmofKabiven Peripheral in None, sponsored by Fresenius Kabi. Started Dec 2018; status: completed.
02
Drugs
SmofKabiven Peripheral
Beyond the preview
Go deeper on CTR20182440.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20182440.